These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 28816645)
1. A Systems Model of Parkinson's Disease Using Biochemical Systems Theory. Sasidharakurup H; Melethadathil N; Nair B; Diwakar S OMICS; 2017 Aug; 21(8):454-464. PubMed ID: 28816645 [TBL] [Abstract][Full Text] [Related]
2. TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson's disease. Kang SS; Zhang Z; Liu X; Manfredsson FP; Benskey MJ; Cao X; Xu J; Sun YE; Ye K Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10773-10778. PubMed ID: 28923922 [TBL] [Abstract][Full Text] [Related]
3. Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease? Bisaglia M; Filograna R; Beltramini M; Bubacco L Ageing Res Rev; 2014 Jan; 13():107-14. PubMed ID: 24389159 [TBL] [Abstract][Full Text] [Related]
4. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease. Yasuda T; Mochizuki H Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696 [TBL] [Abstract][Full Text] [Related]
5. Interplay between α-synuclein and parkin genes: Insights of Parkinson's disease. Sharma K; Chib S; Gupta A; Singh R; Chalotra R Mol Biol Rep; 2024 Apr; 51(1):586. PubMed ID: 38683365 [TBL] [Abstract][Full Text] [Related]
6. A pragmatic approach to biochemical systems theory applied to an alpha-synuclein-based model of Parkinson's disease. Sass MB; Lorenz AN; Green RL; Coleman RA J Neurosci Methods; 2009 Apr; 178(2):366-77. PubMed ID: 19136028 [TBL] [Abstract][Full Text] [Related]
7. Analysis of dopaminergic neuronal dysfunction in genetic and toxin-induced models of Parkinson's disease in Drosophila. Navarro JA; Heßner S; Yenisetti SC; Bayersdorfer F; Zhang L; Voigt A; Schneuwly S; Botella JA J Neurochem; 2014 Nov; 131(3):369-82. PubMed ID: 25040725 [TBL] [Abstract][Full Text] [Related]
8. Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde. Lima VA; do Nascimento LA; Eliezer D; Follmer C ACS Chem Neurosci; 2019 Jan; 10(1):690-703. PubMed ID: 30352158 [TBL] [Abstract][Full Text] [Related]
10. Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC. Palazzi L; Fongaro B; Leri M; Acquasaliente L; Stefani M; Bucciantini M; Polverino de Laureto P Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199427 [TBL] [Abstract][Full Text] [Related]
11. Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL). Follmer C; Coelho-Cerqueira E; Yatabe-Franco DY; Araujo GD; Pinheiro AS; Domont GB; Eliezer D J Biol Chem; 2015 Nov; 290(46):27660-79. PubMed ID: 26381411 [TBL] [Abstract][Full Text] [Related]
12. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation. Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854 [TBL] [Abstract][Full Text] [Related]
13. Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson's disease (PD) - A road to discovery? Jayaramayya K; Iyer M; Venkatesan D; Balasubramanian V; Narayanasamy A; Subramaniam MD; Cho SG; Vellingiri B Brain Res Bull; 2020 Apr; 157():169-179. PubMed ID: 32035946 [TBL] [Abstract][Full Text] [Related]
14. Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson's disease model. Ham S; Lee YI; Jo M; Kim H; Kang H; Jo A; Lee GH; Mo YJ; Park SC; Lee YS; Shin JH; Lee Y Sci Rep; 2017 Apr; 7(1):525. PubMed ID: 28366931 [TBL] [Abstract][Full Text] [Related]
15. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons. Decressac M; Mattsson B; Lundblad M; Weikop P; Björklund A Neurobiol Dis; 2012 Mar; 45(3):939-53. PubMed ID: 22182688 [TBL] [Abstract][Full Text] [Related]
16. Mitochondria-mediated damage to dopaminergic neurons in Parkinson's disease (Review). Liu XL; Wang YD; Yu XM; Li DW; Li GR Int J Mol Med; 2018 Feb; 41(2):615-623. PubMed ID: 29207041 [TBL] [Abstract][Full Text] [Related]
17. [The role of parkin in Parkinson's disease]. Miklya I; Göltl P; Hafenscher F; Pencz N Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049 [TBL] [Abstract][Full Text] [Related]
18. Generation of a alpha-synuclein-based rat model of Parkinson's disease. Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315 [TBL] [Abstract][Full Text] [Related]